NCT03004131View on ClinicalTrials.gov

MP-AzeFlu Allergen Chamber - Onset of Action Study

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 7, 2017

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Azelastine hydrochloride + fluticasone propionate nasal spray

DRUG

Placebos

DRUG

fluticasone propionate nasal spray + loratadine

Trial Locations (1)

L4W1Ae

Inflamax Research, Mississauga

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT03004131 - MP-AzeFlu Allergen Chamber - Onset of Action Study | Biotech Hunter | Biotech Hunter